Biblio Discovery — Demo Discovery Service

4 results for "Mali Cosden"

Showing 1–4 · 0.24 seconds · RSS

  1. Journal Article

    Glucosylsphingosine is a potential fluid-based biomarker of lysosomal dysfunction in Cln3Δex7/8 mice

    Hallie Wald; Stephanie Cicalese; Lihang Yao et al.

    Neurobiology of Disease, Vol. 214 · 2025 · English · DOAJ Scopus

    CLN3 disease is a rare fatal juvenile neurodegenerative lysosomal storage disease. Challenges in tracking underlying disease biology have hindered the identification of effective therapeutic targets and the ability to execute clinical trials in this rare disease. While diagnostic biomarkers are…

  2. Journal Article Full text

    Decreased glucocerebrosidase activity and substrate accumulation of glycosphingolipids in a novel GBA1 D409V knock-in mouse model

    Nicole K. Polinski; Terina N. Martinez; Alexander Gorodinsky et al.

    PLOS ONE, Vol. 16 No. 6 · 2021 · English · PLOS Scopus

    Multiple mutations have been described in the human GBA1 gene, which encodes the lysosomal enzyme beta-glucocerebrosidase (GCase) that degrades glucosylceramide and is pivotal in glycosphingolipid substrate metabolism. Depletion of GCase, typically by homozygous mutations in GBA1, is linked to the…

    Also available at: DOAJ

  3. Journal Article

    A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy

    Mali Cosden; Sarah Jinn; Lihang Yao et al.

    Neurobiology of Disease, Vol. 159 · 2021 · English · DOAJ Scopus

    Mutations in the lysosomal enzyme glucocerebrosidase (GCase, GBA1 gene) are the most common genetic risk factor for developing Parkinson's disease (PD). GCase metabolizes the glycosphingolipids glucosylceramide (GlcCer) and glucosylsphingosine (GlcSph). Mutations in GBA1 reduce enzyme activity and…